{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐99a (miR‑99a), a member of the evolutionarily conserved miR‑99 family, is emerging as an important tumor suppressor whose expression is significantly downregulated in a wide spectrum of human malignancies—including hepatocellular, renal, breast, thyroid, oral, lung, and esophageal cancers. Reduced miR‑99a levels in tumor tissues have been closely associated with aggressive clinicopathological features, enhanced stem‐like properties and metastatic behavior, as well as poorer patient survival, highlighting its clinical relevance as a prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistically, miR‑99a exerts its tumor‐suppressive function by directly targeting multiple key regulators of cell growth, survival, and differentiation. Several studies have identified the mammalian target of rapamycin (mTOR) as a prominent direct target, with miR‑99a–mediated mTOR downregulation resulting in cell cycle arrest, inhibition of proliferation, and enhanced apoptosis. In addition, miR‑99a regulates other oncogenic pathways by suppressing transcripts such as IGF‑1 receptor, fibroblast growth factor receptor 3 (FGFR3), and NOX4, as well as by controlling epigenetic networks—for example, through its repression by long noncoding RNAs like ANRIL in gastric cancer. Together, these molecular interactions position miR‑99a as a central node in the regulation of critical signaling cascades including PI3K/Akt/mTOR and cell cycle regulators such as CDC25A and HOXA1."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe preclinical data further suggest that restoration of miR‑99a can re‐sensitize cancer cells to therapeutic interventions. Enhanced miR‑99a expression has been shown to inhibit tumor growth, impair cell migration and invasion, and overcome resistance to chemotherapeutic agents (such as cisplatin and vincristine) and targeted treatments (for example, anti‐EGFR or sunitinib therapy). In several tumor models, overexpression of miR‑99a not only suppressed epithelial–mesenchymal transition and reduced cancer stem cell properties but also improved responses to radiotherapy and other combination treatments—underscoring its potential as both a prognostic marker and a therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "S Venkatachalam, S D Tyner, C R Pickering, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Pathol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/019262301753178555"}], "href": "https://doi.org/10.1080/019262301753178555"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11695551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11695551"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Dong Li, Xingguang Liu, Li Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111.270561"}], "href": "https://doi.org/10.1074/jbc.M111.270561"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21878637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21878637"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Li Cui, Hua Zhou, Hu Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-12-546"}], "href": "https://doi.org/10.1186/1471-2407-12-546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23173671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23173671"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Jian Sun, Zhaoli Chen, Xiaogang Tan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-012-0411-9"}], "href": "https://doi.org/10.1007/s12032-012-0411-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23292834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23292834"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Yu Hu, Qin Zhu, Lili Tang "}, {"type": "b", "children": [{"type": "t", "text": "MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0092099"}], "href": "https://doi.org/10.1371/journal.pone.0092099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24637915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24637915"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hou-Gang Huang, Xi Luo, Shuai Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Asian Pac J Cancer Prev (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7314/apjcp.2015.16.12.4937"}], "href": "https://doi.org/10.7314/apjcp.2015.16.12.4937"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26163618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26163618"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xiaolong Wang, Yaming Li, Wenwen Qi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.5355"}], "href": "https://doi.org/10.18632/oncotarget.5355"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26417931"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26417931"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Mei Sun, Shunming Hong, Wenhan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2016.4672"}], "href": "https://doi.org/10.3892/or.2016.4672"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26986073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26986073"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Dandan Sun, Yong Sun Lee, Ankit Malhotra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1031"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1031"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21212412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21212412"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Brittany C Parker, Matti J Annala, David E Cogdell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI67144"}], "href": "https://doi.org/10.1172/JCI67144"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23298836"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23298836"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "D Sun, R Layer, A C Mueller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2013.77"}], "href": "https://doi.org/10.1038/onc.2013.77"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23503464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23503464"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yi Jin, Stéphanie D Tymen, Dan Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-99 family targets AKT/mTOR signaling pathway in dermal wound healing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0064434"}], "href": "https://doi.org/10.1371/journal.pone.0064434"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23724047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23724047"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "F Akbari Moqadam, E A M Lange-Turenhout, I M Ariës, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2013.06.027"}], "href": "https://doi.org/10.1016/j.leukres.2013.06.027"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23915977"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23915977"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Er-bao Zhang, Rong Kong, Dan-dan Yin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.1902"}], "href": "https://doi.org/10.18632/oncotarget.1902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24810364"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24810364"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Z Yang, Y Han, K Cheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12146"}], "href": "https://doi.org/10.1111/cpr.12146"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25348507"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25348507"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yong Lin, Wanyu Deng, Jinke Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The microRNA-99 family modulates hepatitis B virus replication by promoting IGF-1R/PI3K/Akt/mTOR/ULK1 signaling-induced autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Microbiol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cmi.12709"}], "href": "https://doi.org/10.1111/cmi.12709"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27886437"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27886437"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Y Shi, Z Bo, G Pang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-99a-5p regulates proliferation, migration and invasion abilities of human oral carcinoma cells by targeting NOX4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2017_503"}], "href": "https://doi.org/10.4149/neo_2017_503"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28592118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28592118"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "C Oneyama, J Ikeda, D Okuzaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.63"}], "href": "https://doi.org/10.1038/onc.2011.63"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21383697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21383697"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "X-J Li, X-Q Luo, B-W Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2013.562"}], "href": "https://doi.org/10.1038/bjc.2013.562"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24030073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24030073"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Li Wang, Lihua Chang, Zhaorong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-99a and -99b inhibit cervical cancer cell proliferation and invasion by targeting mTOR signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-014-0934-3"}], "href": "https://doi.org/10.1007/s12032-014-0934-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24668416"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24668416"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Shi-huan Yu, Chun-ling Zhang, Fu-shi Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.24965"}], "href": "https://doi.org/10.1002/jcb.24965"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25187230"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25187230"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Sonia Molina-Pinelo, Amancio Carnero, Fernando Rivera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-14-656"}], "href": "https://doi.org/10.1186/1471-2407-14-656"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25197016"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25197016"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Bo Hou, Hajime Ishinaga, Kaoru Midorikawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2015.1045692"}], "href": "https://doi.org/10.1080/15384047.2015.1045692"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25950115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25950115"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "K-Y Lin, H Ye, B-W Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2015.396"}], "href": "https://doi.org/10.1038/onc.2015.396"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26455324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26455324"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jayant K Rane, Holger H H Erb, Giovanna Nappo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10207"}], "href": "https://doi.org/10.18632/oncotarget.10207"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27340920"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27340920"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yajie Zhang, Wenxia Xu, Pan Ni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/ijbs.16529"}], "href": "https://doi.org/10.7150/ijbs.16529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27994509"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27994509"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Takayuki Arai, Atsushi Okato, Yasutaka Yamada, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.1455"}], "href": "https://doi.org/10.1002/cam4.1455"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29608247"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29608247"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Pengyu Jing, Nan Zhao, Mingxiang Ye, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2018.04.019"}], "href": "https://doi.org/10.1016/j.canlet.2018.04.019"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29679612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29679612"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Yudi Geng, Cong Sui, Yang Xun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-99a can regulate proliferation and apoptosis of human granulosa cells via targeting IGF-1R in polycystic ovary syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Assist Reprod Genet (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10815-018-1335-x"}], "href": "https://doi.org/10.1007/s10815-018-1335-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30374732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30374732"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Yoichi Osako, Hirofumi Yoshino, Takashi Sakaguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2019.4736"}], "href": "https://doi.org/10.3892/ijo.2019.4736"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30816432"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30816432"}]}]}]}